CIPROFLOXACIN IN THE TREATMENT OF PNEUMONIA

被引:29
作者
ERNST, JA [1 ]
SY, ER [1 ]
COLONLUCCA, H [1 ]
SANDHU, N [1 ]
RALLOS, T [1 ]
LORIAN, V [1 ]
机构
[1] BRONX LEBANON HOSP CTR,MICROBIOL SECT,BRONX,NY 10456
关键词
D O I
10.1128/AAC.29.6.1088
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:1088 / 1089
页数:2
相关论文
共 5 条
[1]   INVITRO ACTIVITY OF CIPROFLOXACIN, A NEW CARBOXYQUINOLINE ANTIMICROBIAL AGENT [J].
ELIOPOULOS, GM ;
GARDELLA, A ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (03) :331-335
[2]   MULTIPLE-DOSE PHARMACOKINETICS AND SAFETY OF CIPROFLOXACIN IN NORMAL VOLUNTEERS [J].
GONZALEZ, MA ;
URIBE, F ;
MOISEN, SD ;
FUSTER, AP ;
SELEN, A ;
WELLING, PG ;
PAINTER, B .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (05) :741-744
[3]   CIPROFLOXACIN PENETRATION INTO EXTRAVASCULAR SPACES IN A RABBIT MODEL [J].
NICHOL, KL ;
PETERSON, LR ;
FASCHING, CE ;
GERDING, DN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (06) :935-936
[4]   INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS [J].
WISE, R ;
ANDREWS, JM ;
EDWARDS, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) :559-564
[5]  
1983, APPROVED PERFORMANCE